2 No-Brainer Healthcare Stocks to Buy Now
The obesity drug market is creating trillion-dollar winners, but you don't have to pay premium prices for exposure. (NYSE: PFE) and Viking Therapeutics (NASDAQ: VKTX) are both relatively inexpensive compared to their opportunities in obesity. One offers a high-yield blue chip that just spent $10 billion entering the space, while the other is a pure-play biotech with late-stage programs in both injectable and oral weight-loss drugs.
Here's why these two healthcare stocks scan as no-brainer buys right now.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Stock
€21.99
-0.390%
We see a rather positive sentiment for Pfizer Inc. with 15 Buy predictions and 2 Sell predictions.
As a result the target price of 27 € shows a positive potential of 22.78% compared to the current price of 21.99 € for Pfizer Inc..
